Vaginal DHEA linked with decreased UTI prevalence in patients with GSM

madman

Super Moderator
“Those who were on this vaginal DHEA had a huge decrease in the prevalence of urinary tract infections in the 1 year after getting the prescription,” says Rachel S. Rubin, MD.


In this video, Rachel S. Rubin, MD, discusses the background and notable findings from the 2023 American Urological Association Annual Meeting abstract “Impact of vaginal prasterone on the rate of urinary tract infections in GSM patients and those with a history of breast cancer: a retrospective cohort analysis.” Rubin is a urologist and sexual medicine specialist in private practice in Rockville, Maryland, and also an assistant clinical professor in urology at Georgetown University Hospital, Washington, DC.
 

Online statistics

Members online
1
Guests online
305
Total visitors
306

Latest posts

Back
Top